These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 25047668)
41. [Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)]. Sobue G Rinsho Shinkeigaku; 2010 Nov; 50(11):839-41. PubMed ID: 21921465 [TBL] [Abstract][Full Text] [Related]
42. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy. Pennuto M; Basso M J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347 [TBL] [Abstract][Full Text] [Related]
43. Somatic stability of the expanded CAG trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Spiegel R; La Spada AR; Kress W; Fischbeck KH; Schmid W Hum Mutat; 1996; 8(1):32-7. PubMed ID: 8807333 [TBL] [Abstract][Full Text] [Related]
44. [Two brothers with very late onset of muscle weakness in X-linked recessive spinal and bulbar muscular atrophy]. Hemmi S; Inoue K; Kutoku Y; Rikimaru M; Murakami T; Sunada Y Rinsho Shinkeigaku; 2009 Jan; 49(1):22-6. PubMed ID: 19227892 [TBL] [Abstract][Full Text] [Related]
45. Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Fratta P; Nirmalananthan N; Masset L; Skorupinska I; Collins T; Cortese A; Pemble S; Malaspina A; Fisher EM; Greensmith L; Hanna MG Neurology; 2014 Jun; 82(23):2077-84. PubMed ID: 24814851 [TBL] [Abstract][Full Text] [Related]
46. Diversity in the androgen receptor CAG repeat has been shaped by a multistep mutational mechanism. Santos D; Pimenta J; Wong VC; Amorim A; Martins S Am J Med Genet B Neuropsychiatr Genet; 2014 Oct; 165B(7):581-6. PubMed ID: 25078541 [TBL] [Abstract][Full Text] [Related]
47. Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy. Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK Muscle Nerve; 2018 Apr; 57(4):683-686. PubMed ID: 28972672 [TBL] [Abstract][Full Text] [Related]
48. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Igarashi S; Tanno Y; Onodera O; Yamazaki M; Sato S; Ishikawa A; Miyatani N; Nagashima M; Ishikawa Y; Sahashi K Neurology; 1992 Dec; 42(12):2300-2. PubMed ID: 1461383 [TBL] [Abstract][Full Text] [Related]
50. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Bott LC; Badders NM; Chen KL; Harmison GG; Bautista E; Shih CC; Katsuno M; Sobue G; Taylor JP; Dantuma NP; Fischbeck KH; Rinaldi C Hum Mol Genet; 2016 May; 25(10):1979-1989. PubMed ID: 26962150 [TBL] [Abstract][Full Text] [Related]
51. Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy. Walcott JL; Merry DE Vitam Horm; 2002; 65():127-47. PubMed ID: 12481545 [TBL] [Abstract][Full Text] [Related]
52. Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease. Arnold FJ; Merry DE Neurotherapeutics; 2019 Oct; 16(4):928-947. PubMed ID: 31686397 [TBL] [Abstract][Full Text] [Related]
53. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355 [TBL] [Abstract][Full Text] [Related]
54. In vivo expansion of trinucleotide repeats yields plasmid and YAC constructs for targeting and transgenesis. Sopher BL; Myrick SB; Hong JY; Smith AC; La Spada AR Gene; 2000 Dec; 261(2):383-90. PubMed ID: 11167027 [TBL] [Abstract][Full Text] [Related]
55. Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals. Kuhlenbäumer G; Kress W; Ringelstein EB; Stögbauer F J Neurol; 2001 Jan; 248(1):23-6. PubMed ID: 11266016 [TBL] [Abstract][Full Text] [Related]
56. Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. Beitel LK; Scanlon T; Gottlieb B; Trifiro MA Neurotox Res; 2005; 7(3):219-30. PubMed ID: 15897156 [TBL] [Abstract][Full Text] [Related]
58. [A clinical, neurophysiological and molecular study of 12 patients from 4 families with spinal and bulbar muscular atrophy]. Echaniz-Laguna A; Rousso E; Anheim M; Fleury M; Cossée M; Tranchant C Rev Neurol (Paris); 2005 Apr; 161(4):437-44. PubMed ID: 15924079 [TBL] [Abstract][Full Text] [Related]
60. [In vitro aggregation and cellular toxicity of mutant androgen receptor protein in spinal and bulbar muscular atrophy]. Kobayashi Y; Li M; Sobue G Nihon Rinsho; 1999 Apr; 57(4):874-9. PubMed ID: 10222782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]